- Activity pressure is positive on the latest completed week.
GENT
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Gentian Diagnostics ASA · Healthcare · Medical Devices
Latest close
40.70 NOK
2.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned 2.3%, after a 6.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
35
out of 100
Latest Close
40.70 NOK
7 Aug 2026
1W Return
2.3%
latest completed week
4W Return
6.0%
short-term follow-through
12W Return
3.0%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.84% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.3%
Latest completed week; four-week move 6.0%.
Indicator stack
11/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.84%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 26.0% of its 52-week range. The latest completed week returned 2.3%, after a 6.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1512-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.0% over four weeks, 3.0% over 12 weeks, and -26.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.69Latest activity-pressure read.
Pressure change4717.9%Four-week change in activity pressure.
Leadership-24.48Latest relative-leadership reading.
RS change13.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.2%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2611 weeks finished lower.
Best week+16.8%Week of 20 Feb.
Worst week-34.3%Week of 13 Feb.
Latest week+2.3%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks2
Modest losses7
Sharp losses4
Recent vol3.8%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split25/25Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank8 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Medical Devices
4-week rank2 / 4
Group average3.3%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.15; No reversal markers Next-Week ExpectancyNegative 43.84%Next-week expectancy is negative with a 43.84% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
GENT: Record Q2 sales, strong U.S./Europe growth, and new R&D strategy drive future momentum Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 40.70 NOK | 2.3% | 41.49 NOK | 45.58 NOK | 0.69 | -24.48 | 11.9K | Off |
| 31 Jul 2026 | 39.80 NOK | 0.0% | 42.04 NOK | 45.60 NOK | 0.57 | -26.61 | 29.1K | Off |
| 24 Jul 2026 | 39.80 NOK | -1.0% | 42.60 NOK | 45.64 NOK | 0.36 | -27.09 | 35.1K | Off |
| 17 Jul 2026 | 40.20 NOK | 4.7% | 43.10 NOK | 45.68 NOK | 0.15 | -25.16 | 6.0K | Off |
| 10 Jul 2026 | 38.40 NOK | 3.8% | 43.65 NOK | 45.71 NOK | 0.01 | -28.29 | 28.2K | Off |
| 3 Jul 2026 | 37.00 NOK | 2.8% | 44.27 NOK | 45.76 NOK | -0.14 | -32.05 | 936 | Off |
| 26 Jun 2026 | 36.00 NOK | -3.7% | 44.84 NOK | 45.80 NOK | -0.16 | -33.26 | 0 | Off |
| 19 Jun 2026 | 37.40 NOK | 5.9% | 45.40 NOK | 45.87 NOK | -0.17 | -33.33 | 940 | Off |
| 12 Jun 2026 | 35.30 NOK | -3.3% | 45.92 NOK | 45.92 NOK | -0.16 | -39.19 | 4.5K | Off |
| 5 Jun 2026 | 36.50 NOK | 1.4% | 46.54 NOK | 46.00 NOK | -0.14 | -38.19 | 610 | Off |
| 29 May 2026 | 36.00 NOK | -0.3% | 47.19 NOK | 46.05 NOK | -0.17 | -39.71 | 43.9K | Off |
| 22 May 2026 | 36.10 NOK | -8.6% | 47.81 NOK | 46.11 NOK | -0.18 | -41.52 | 34.2K | Off |
| 15 May 2026 | 39.50 NOK | 2.3% | 48.35 NOK | 46.17 NOK | -0.30 | -35.96 | 20.9K | Off |
| 8 May 2026 | 38.60 NOK | -12.3% | 48.84 NOK | 46.21 NOK | -0.39 | -36.57 | 121.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.